Error: Could not add to watchlist. X
+ Watchlist

Adaptimmune Therapeutics Plc

ADAP:US
NASDAQ GS
7.93
USD
0.48
5.71%
As of 8:10 PM EDT 9/22/2017
Open
8.16
Day Range
7.79 - 8.20
Volume
567,538
Previous Close
8.41
52Wk Range
3.76 - 9.29
1 Yr Return
11.38%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
8.16
Day Range
7.79 - 8.20
Volume
567,538
Previous Close
8.41
52Wk Range
3.76 - 9.29
1 Yr Return
11.38%
YTD Return
95.80%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.17
Market Cap (m USD)
741.606
Shares Outstanding (m)
93.519
Price/Sales (TTM)
204.54
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.08%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company develops novel cancer immunotherapy products based on T-cell receptor platform that helps to identify cancer targets. Adaptimmune Therapeutics serves customers worldwide.
Address
91 Park Drive
Milton Park
Abingdon, OX14 4RY
United Kingdom
Phone
44-1235-430-000
Show More